We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New System Enables Multi-Color Resolution in Cells

By LabMedica International staff writers
Posted on 05 Jun 2017
Print article
Image: The Leica DMi8 S imaging system (Photo courtesy of Leica Microsystems).
Image: The Leica DMi8 S imaging system (Photo courtesy of Leica Microsystems).
A powerful microscope imaging system provides five times more speed and an increased viewing area up to 10,000 times, which can be combined with a new photomanipulation scanner to activate, ablate, and bleach cells or molecules within one experiment.

The Leica (Wetzler, Germany) DMi8 S imaging system was launched at the 17th International European Light Microscopy Initiative Meeting (ELMI) that was held in Dubrovnik, Croatia, May 23-26, 2017.

The imaging system is based on the DMi8 modular research microscope. This advanced instrument is fully configurable with manual or motorized accessories, and the system can be adapted or upgraded at any time. The Leica DMi8 was designed with flexibility in mind. With up to two Infinity Ports providing access points for addition of fluorescent devices, the microscope is easily adaptable for applications ranging from simple fluorescent imaging to sophisticated super resolution techniques. This novel design facilitates the integration of additional fluorescence light sources and laser systems for advanced applications like FRAP (fluorescence recovery after photobleaching), photo-switching, ablation, optogenetics, and more.

With the highly flexible Infinity TIRF (total internal reflection fluorescence) module, researchers can produce simultaneous multicolor illumination, and by employing the high power illumination option, perform super resolution applications. These options enable the researcher to achieve multi-color single molecule resolution at the cell surface to resolve structures involved in receptor trafficking, synaptic organization, or cell adhesion. With the high-powered lasers option, it is possible to image and analyze samples down to a resolution of 20 nanometers.

“Live-cell imaging is the future in discoveries. Gaining insight on dynamic processes is key to understand the mechanisms, potential treatments, and prevention of human diseases,” said Markus Lusser, president of Leica Microsystems. “These new DMi8 S developments have far reaching utility. Whether studying neuroscience, cancer, or immunology, researchers can use the DMi8 S to get elusive answers to their questions and find the links to our complex biology.”

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more